GAtherton

🫁 Understanding Bronchiectasis, COPD, and Aspergillosis: What Patients Need to Know

Living with a lung condition can be confusing — especially when the symptoms of bronchiectasis, COPD, and aspergillosis are so similar. This guide explains the differences, how they are diagnosed, and why many people are wrongly diagnosed (or underdiagnosed) at first.

🌬️ What Are These Conditions?

Bronchiectasis

A condition where the airways become damaged, widened, and scarred, often from past infections, immune problems, or conditions like ABPA or CPA. This makes it hard to clear mucus, leading to regular infections.

COPD (Chronic Obstructive Pulmonary Disease)

A group of conditions — including emphysema and chronic bronchitis — that cause narrowed airways and damaged air sacs. Most often caused by smoking or long-term exposure to fumes or dust.

Aspergillosis

An infection or allergic reaction caused by the fungus Aspergillus. Types include:

  • ABPA (allergic bronchopulmonary aspergillosis) — mostly in asthma or bronchiectasis

  • CPA (chronic pulmonary aspergillosis) — causes lung cavities and fungal balls

  • Aspergillus bronchitis — low-grade infection in people with bronchiectasis

🔄 Shared Symptoms

All three can cause:

Symptom Bronchiectasis COPD Aspergillosis
Chronic cough ✅ ✅ ✅
Sputum (phlegm) ✅ (often a lot) ✅ (varies) ✅ (sticky, sometimes brown)
Breathlessness ✅ ✅ ✅
Recurrent infections ✅ ✅ ✅
Fatigue ✅ ✅ ✅
Wheezing Sometimes ✅ ✅ in ABPA
Coughing blood (haemoptysis) ✅ ⚠️ ✅ (especially in CPA)

Because the symptoms are so similar, many people with aspergillosis are first told they have COPD or bronchiectasis until further tests are done.

🖥️ How Are They Diagnosed?

🧪 Tests Used

Test Helps Diagnose
Spirometry (lung function) COPD or asthma (airflow obstruction)
High-resolution CT scan Bronchiectasis, CPA, emphysema
Aspergillus IgG & IgE blood tests CPA (IgG), ABPA (IgE)
Sputum culture or PCR Finds Aspergillus or bacterial infections
Eosinophil count High in ABPA
Chest X-ray May show cavities, but CT is better

🫁 CT Scan Signs: What Do Radiologists Look For?

Feature Bronchiectasis COPD CPA / Aspergillosis
Airway shape Widened, thickened (signet-ring sign) Narrowed or normal May have overlapping bronchiectasis
Lung tissue Scarring, mucus plugging Blackened areas (emphysema) Cavities, fungal balls, fibrosis
Mucus Often present Sometimes present Mucus or fungus in airways
Other signs Tree-in-bud, cystic changes Air trapping, flattened diaphragm Thickened cavity walls, pleural changes

💨 What Are Air Trapping and Hyperinflation?

These are signs that air is getting stuck in the lungs — common in asthma, COPD, ABPA, and sometimes CPA.

🔹 Air trapping

Air gets into the lungs but can’t get out fully. You may feel like you can’t finish exhaling.

  • Seen on CT scan as dark areas during breathing out.

  • Lung function tests show high residual volume (RV).

  • Common in asthma, ABPA, bronchiectasis, and COPD.

🔹 Hyperinflation

The lungs are permanently overfilled with air, even when you’re not trying to breathe in.

  • Seen on CT/X-ray as large lungs, flattened diaphragm, and horizontal ribs.

  • Lung function shows high total lung capacity (TLC).

  • Common in emphysema, severe asthma, and ABPA.

Why it matters: Both conditions make breathing harder and less efficient, especially when active. Treatment like inhalers, antifungals, airway clearance, or biologics may help.

💊 Treatment Approaches

Treatment Bronchiectasis COPD Aspergillosis
Airway clearance physiotherapy ✅ Essential Sometimes ✅ Often vital
Antibiotics ✅ Regularly used During flares ✅ For Aspergillus bronchitis/CPA
Inhalers (bronchodilators) Sometimes helpful ✅ Core treatment ✅ In ABPA if asthma is present
Steroids In flares or ABPA ✅ Often ✅ In ABPA
Antifungals (e.g. itraconazole, voriconazole) ❌ Not routine ❌ ✅ Main treatment for CPA/ABPA
Pulmonary rehab ✅ ✅ ✅ May help fatigue/breathlessness
Oxygen Rare ✅ In advanced disease ✅ In some advanced cases

🧠 Why It’s Complicated

Many patients are misdiagnosed at first:

  • Aspergillosis can develop on top of COPD or bronchiectasis

  • A long delay in diagnosis is common

  • Some people have all three conditions, or overlapping features (e.g. COPD + ABPA)

That’s why blood tests and CT scans are so important — symptoms alone aren’t enough.

✅ Summary Table

Feature Bronchiectasis COPD Aspergillosis
Cause Infection, immune issues Smoking, pollutants Fungal allergy or infection
Airway problem Widened, mucus-filled Narrowed, damaged sacs Cavities, fungus growth or allergy
Diagnostic test CT scan Spirometry CT + Aspergillus IgG/IgE
Key treatment Clearance + antibiotics Inhalers, steroids Antifungals ± steroids

💬 What Should I Ask My Doctor?

  • Could my symptoms be due to more than one condition?

  • Have I had a CT scan and Aspergillus blood tests?

  • Should I be seen by a specialist centre (e.g. for ABPA or CPA)?

  • Am I using the right inhalers or physiotherapy?

  • Could I benefit from a sputum test or antifungal treatment?

by GAtherton

🩺 Lung Function Tests Explained: What They Tell Us About Asthma, COPD, Bronchiectasis, and Aspergillosis

If you’re living with a lung condition like asthma, COPD, bronchiectasis, or aspergillosis, you may be asked to have a lung function test. These tests help your medical team understand how well your lungs are working — and how best to treat you.

🌬️ What Are Lung Function Tests?

Lung function tests (also called pulmonary function tests) measure:

  • How fast and deeply you can breathe

  • How well your lungs move oxygen into your blood

  • How much air gets trapped in your lungs

🔬 Main Tests and What They Measure

Test What It Measures Why It Matters
Spirometry Speed and volume of air breathed out Shows obstruction or reversibility (e.g. in asthma)
Lung volumes Total size of the lungs and air left after exhaling Detects air trapping and hyperinflation
Gas transfer (DLCO) How well gases pass from lungs to blood Can show scarring, emphysema, or CPA
Bronchodilator test Measures response to inhaler Helps diagnose asthma or ABPA

🧠 What Do These Tests Tell Us?

Here’s how different conditions show up in lung function testing:

🟢 Asthma

  • Airways are narrowed, but often improve with inhalers.

  • Shows obstruction that improves significantly after a bronchodilator (reversible).

  • Lung volumes usually normal; DLCO often normal or high.

🔵 COPD

  • Shows irreversible obstruction — lungs are stiff and narrowed.

  • Often shows air trapping and hyperinflation.

  • DLCO is reduced, especially in emphysema.

🟠 Bronchiectasis

  • May show mild-to-moderate obstruction or mixed patterns.

  • Sometimes reversible, depending on overlapping asthma or infection.

  • Lung volumes and DLCO often normal unless CPA or emphysema is also present.

🟣 Aspergillosis

  • ABPA: Like asthma — obstruction, often with reversibility, air trapping, high IgE and eosinophils.

  • CPA: May cause a restrictive pattern (lower lung volumes) or reduced DLCO if fibrosis or cavities are present.

  • Aspergillus bronchitis: May look like bronchiectasis with some obstruction.

💨 What Is Air Trapping?

Air trapping happens when you breathe in, but can’t get all the air back out. Some air stays stuck in the lungs.

Sign What It Means
High residual volume (RV) Too much air remains after breathing out
Expiratory CT scan shows dark areas Parts of the lungs aren’t emptying properly

Common in:

  • Asthma

  • ABPA

  • Bronchiectasis

  • COPD

🎈 What Is Hyperinflation?

Hyperinflation means your lungs are constantly overfilled with air — not just trapped temporarily, but stretched long-term.

Sign What It Means
High total lung capacity (TLC) Lungs are too large due to long-term air trapping
Flattened diaphragm Lungs are pressing downward on breathing muscles

Common in:

  • Severe asthma

  • Emphysema (COPD)

  • ABPA (when uncontrolled)

📊 Summary Table

Condition Common Lung Test Features
Asthma Obstruction, reversible, normal DLCO
ABPA Obstruction, reversible, air trapping, high IgE
COPD Fixed obstruction, hyperinflation, low DLCO
Bronchiectasis Variable obstruction, sometimes reversible
CPA Restriction or mixed pattern, reduced DLCO
Aspergillus bronchitis Similar to bronchiectasis, sputum positive for fungus

💬 Why These Tests Matter

  • They help distinguish what’s causing your symptoms.

  • They track whether treatment is working (inhalers, steroids, antifungals).

  • They identify complications like scarring, cavities, or fungal infection.

  • They help guide eligibility for biologic drugs or oxygen therapy.

📣 Ask Your Doctor:

  • Have I had a bronchodilator response test?

  • Do I have air trapping or hyperinflation?

  • Should we test for Aspergillus (IgG, IgE, sputum)?

  • Would a CT scan add helpful detail?

by GAtherton

🟣 Aspergillus Bronchitis: A Patient Guide

If you've been diagnosed with bronchiectasis, COPD, or other chronic lung problems, and keep getting infections or mucus that tests positive for Aspergillus, you might be told you have Aspergillus bronchitis. But what does that mean? And how is it different from ABPA (Allergic Bronchopulmonary Aspergillosis)?

This guide explains what Aspergillus bronchitis is, how it’s diagnosed, how common it is, and how it differs from ABPA.

🌬️ What Is Aspergillus Bronchitis?

Aspergillus bronchitis is a chronic fungal infection of the airways caused by Aspergillus fumigatus. It happens in people with damaged or scarred airways, such as:

  • Bronchiectasis

  • COPD

  • Cystic fibrosis

  • Occasionally asthma (if structural damage exists)

It’s a low-grade infection, not an allergy and not an invasive disease. The fungus lives in the mucus lining the airways, causing persistent inflammation, infection, and symptoms.

🔍 What Are the Symptoms?

Common symptoms What to know
Persistent cough Often brings up sticky or brown mucus
Worsening breathlessness Not always explained by asthma or infection alone
Fatigue or low energy Common in chronic fungal infections
Frequent infections May keep returning despite antibiotics
Wheeze Sometimes, especially in asthma or ABPA overlap
Weight loss or low-grade fever Possible in long-standing infection

📊 How Common Is It?

Aspergillus bronchitis is underdiagnosed but increasingly recognised — especially in patients referred to specialist centres.

Estimated frequency in different conditions:

Underlying condition Estimated rate of Aspergillus bronchitis
Bronchiectasis ~5–15%, higher in referral centres
COPD ~1–5%, especially with steroid use
Cystic fibrosis 5–10% (non-allergic cases)
Asthma (alone) Rare unless bronchiectasis is also present

It may be mistaken for a flare-up or chronic bacterial infection. Many people are told it’s “just colonisation” — but if symptoms persist and Aspergillus keeps growing in sputum, Aspergillus bronchitis should be considered.

🧪 How Is It Diagnosed?

There’s no single test. Diagnosis is based on clinical features plus evidence of fungal growth and a non-allergic immune pattern.

Test What it shows
Sputum culture / PCR Repeated detection of Aspergillus
Aspergillus IgG (blood) Often raised, shows chronic exposure
Aspergillus IgE & eosinophils Usually normal — helps exclude ABPA
CT scan Shows bronchiectasis, mucus plugging, but no cavitation
Response to antifungals Clinical improvement supports diagnosis

🔄 How Is It Different from ABPA?

ABPA is an allergic reaction to Aspergillus that mainly affects people with asthma or cystic fibrosis.
Aspergillus bronchitis, on the other hand, is a fungal infection in damaged airways, not an allergy.

Feature Aspergillus Bronchitis ABPA
Type of disease Chronic fungal infection Allergic lung disease
Immune markers High IgG, normal IgE High IgE and eosinophils
Sputum Repeated growth of Aspergillus May or may not grow
CT findings Bronchiectasis, mucus Central bronchiectasis, mucus plugs
Treatment Antifungals only Steroids ± antifungals
Typical patient Bronchiectasis, COPD Asthma (often severe), sometimes CF

Some patients can have both conditions at once, especially those with asthma and bronchiectasis — so testing is important.

💊 Treatment Options

Treatment Purpose
Oral antifungals (itraconazole, voriconazole) Main treatment — often for several months
Inhaled antifungals (e.g. nebulised amphotericin) Alternative if oral drugs not tolerated
Airway clearance physiotherapy Helps remove mucus and fungal load
Regular sputum testing To monitor treatment response
Steroids Not used unless there’s overlapping ABPA or asthma

🧠 Summary

Question Answer
Is it an infection? ✅ Yes — fungal infection in the airways
Is it an allergy? ❌ No — that’s ABPA
Can it coexist with ABPA? ✅ Yes, in some cases
How is it diagnosed? Repeated Aspergillus in sputum + high IgG + symptoms
How is it treated? Antifungal medication (oral or nebulised)
Will it go away? Often improves with treatment, but monitoring is essential

💬 What to Ask Your Doctor

  • Could my symptoms be from Aspergillus bronchitis?

  • Have I had sputum cultures and Aspergillus blood tests (IgG, IgE)?

  • Would antifungal treatment help me?

  • Should I be referred to a specialist centre (e.g. for CPA, ABPA, bronchiectasis)?

  • Am I on the best airway clearance and physiotherapy plan?

by GAtherton

Dad and the Sneaky Spores

A lovely story commissioned by the Aspergillosis Trust to raise awareness of the condition and to help children understand what it means to live with a family member affected by it. The narrative not only educates readers about Aspergillosis but is also thoughtfully crafted by Christina Gabbitas to foster empathy and understanding.

Dad and the Sneaky Spores : Gabbitas, Christina, Thomas, Rebecca, Hurst, Ursula: Amazon.co.uk: Books

by GAtherton

Aspergillosis Awareness: Conversation with Tom Bermingham - European Lung Foundation

Conversation with Tom Bermingham - European Lung Foundation

👨 Meet Tom Bermingham

  • Lives in rural County Wexford, Ireland, with his wife.

  • Works as a Rural Development Manager.

  • Diagnosed with aspergillosis in 2022 after years of lung issues.

🌪️ What Triggered His Aspergillosis

  • He grew sunflowers in a polytunnel; handling decaying heads released dust he inhaled.

  • Later, home renovation stirred up bathroom mould/dust—both likely exposures.

🏥 The Path to Diagnosis

  • 2019: Hospitalised for cavitating pneumonia and diagnosed with bronchiectasis.

  • Later treated for chronic fatigue syndrome, repeated infections, tiring quickly.

  • Feb 2022: Hospitalised again (17 days), diagnosed with severe adult-onset asthma, oxygen-dependent, with mucus positive for Aspergillus fumigatus.

  • Initially labelled with Chronic Pulmonary Aspergillosis (CPA), treated with steroids, antifungals, inhalers, antibiotics, and fatigue medications.

  • 2024: Diagnosis revised to ABPA + Severe Asthma with Fungal Sensitisation (SAFS).

  • October 2024: Hospitalised for COVID-19 and Pseudomonas lung infection treated via PICC line. European Lung Foundation

💔 How It Affects His Daily Life

  • Mornings bring coughing up “dirty mucus” daily—an unsettling reminder.

  • Extreme fatigue, headaches, regular infections dominate his life.

  • Gave up gardening (risk of soil exposure), community work, and physical chores.

  • Lives with constant fear of infection, medication side effects, and hospitalisations.

  • Chronic disease has made long-term planning impossible; relaxation and mental wellbeing are vital.

🧭 How He Manages

  • Supported by his wife and daughters and his flexible employer.

  • Practices listening to his body: rests when needed.

  • Regular check-ups—including CT scans, lung function, sputum and blood tests—keep his care monitored. European Lung Foundation

  • Accepting limitations while focusing on what he can still do helps his mindset.

✅ Key Insights for Aspergillosis Patients

  • Environmental exposures matter: mould, dust, soil may trigger illness—even long after.

  • Diagnosis can be complex and evolve: often overlaps with asthma, bronchiectasis, ABPA, SAFS.

  • Daily life can change significantly, with physical decline and emotional stress.

  • Support network and personalised care are crucial—family, employer flexibility, specialist monitoring.

  • Self-care and mindset: acceptance, rest, and focusing on abilities, not limitations.

by GAtherton

Aspergillosis Awareness: Conversation with Marcela Candeias - European Lung Foundation

Conversation with Marcela Candeias - European Lung Foundation

👩‍⚖️ Meet Marcela Candeias

🩺 Journey to Diagnosis

  • In 2020, Marcela developed a persistent, worsening cough, extreme fatigue, and significant weight loss.

  • She began coughing up thick mucus that turned green and black, culminating in an intense coughing fit lasting several hours.

  • This was the turning point that led her to seek medical help European Lung Foundation.

🩻 What Aspergillosis Felt Like

  • Severe coughing fits and bloody or discoloured phlegm.

  • Physical exhaustion and weight loss.

  • A clear sign that something serious was happening internally, not just a flare-up of old asthma European Lung Foundation.

⏭️ Why It Matters for Patients

  • Aspergillosis can emerge suddenly—even in people with previous mild asthma.

  • Early recognition of changes (e.g. mucus discoloration, fatigue, cough intensity) is crucial.

  • Once symptoms escalate, urgent medical evaluation is essential.

✅ Key Takeaways for Aspergillosis Patients

What to Watch For Why It Matters
🚨 Persistent cough with coloured or black mucus Red flag—seek medical review
Increasing fatigue and weight loss Indicates disease progression
Severe coughing fits or coughing up blood Requires immediate attention

"One of these fits lasted several hours—that was when I knew something was seriously wrong. European Lung Foundation

📌 Patient Action Guide

  1. If you have asthma or COPD and notice new symptoms—especially dark mucus, weight loss, or fatigue—don’t wait.

  2. Tell your GP or lung specialist that you’re concerned about aspergillosis.

  3. Ask about appropriate testing (e.g. imaging, sputum culture, blood markers).

  4. Early diagnosis can lead to timely treatment and better outcomes.

by GAtherton

🫁 Airway Clearance in Aspergillosis: A Patient Guide

Managing mucus to breathe easier, stay healthier, and feel more in control

💡 Why Is Mucus Clearance Important?

If you’re living with a condition like chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA), or aspergillus bronchitis, you may experience ongoing mucus build-up in your lungs. This can:

  • Make breathing harder

  • Trap infection

  • Cause inflammation and damage

  • Trigger coughing, wheeze or breathlessness

Airway clearance techniques (ACTs) help loosen and remove this mucus, reduce chest infections, and improve daily comfort.

🗣️ “Before I started clearing mucus properly, I thought breathlessness was just something I had to live with. But it’s made a big difference.”

🔧 What Techniques Are Available?

Type Examples Purpose Needs Guidance?
Breathing exercises ACBT (Active Cycle of Breathing), huffing Loosens mucus, clears airways ✅ Yes – to be effective
Postural drainage Lying in specific positions Uses gravity to drain mucus ✅ Yes – to avoid reflux or fatigue
Devices Flutter, Acapella, Aerobika (OPEP devices) Vibrate airways + create back pressure to shift mucus ✅ Yes – to use correctly
Manual techniques Chest percussion, assisted cough Help loosen stubborn mucus ✅ Often needs a helper
Mechanical devices HFCWO (“The Vest”), IPV Used in severe or complex cases ✅ Prescribed in specialist settings

🗣️ “I use the Acapella in the mornings while the kettle boils. It’s part of my routine now – and it really helps.”

🗣️ What Do Other Patients Say?

People with aspergillosis often try more than one method before finding what works best. Here are some common reflections:

On devices:
“The flutter helped a lot once I got the angle and rhythm right – but I needed someone to show me how.”

On ACBT:
“Breathing control and huffing helped me get more up with less effort than coughing all day.”

On adapting to daily life:
“It’s about what fits into your day. If something’s too awkward or tiring, you won’t keep doing it – and that’s okay.”

On trial and error:
“It took me months to find the right technique – but now I can manage my mucus better and avoid antibiotics.”

⚠️ Should I Use a Flutter or Acapella Without Help?

Not at first. These devices are effective only if used correctly. Risks of incorrect use include:

  • Not moving mucus effectively

  • Fatigue or breathlessness

  • Worsening reflux or chest tightness

  • In rare cases, worsening of lung symptoms (e.g., if air trapping occurs)

🗣️ “I bought a device online and started using it myself – but it made me dizzy. A physio later explained I was blowing too hard.”

Always ask your respiratory team or GP for referral to a respiratory physiotherapist before starting.

📝 Patient Decision Guide: Should You Use ACTs?

✅ You may benefit if:

  • You cough up mucus daily or feel it’s “stuck”

  • You’ve had repeated chest infections

  • You live with CPA, ABPA, bronchiectasis, or aspergillus bronchitis

❌ Don’t start without guidance if:

  • You have COPD, asthma, or lung scarring

  • You’ve had haemoptysis (coughing up blood)

  • You experience dizziness, nausea, or chest pain during breathing exercises

  • You have gastric reflux or recent chest surgery

🧑‍⚕️ What Can I Start Safely at Home?

Without needing equipment, you can begin with:

  • 💧 Drink plenty of fluids – thin mucus is easier to clear

  • 🪑 Sit upright – especially when coughing or during infections

  • 🌬️ Use breathing control – calm, gentle breaths can reduce breathlessness

  • 🗣️ Try huffing – like breathing out a mirror; easier than deep coughing

🗣️ “Even on days when I’m tired, I try to stay upright and do a few rounds of breathing exercises. It’s become a habit that helps.”

🧭 Next Steps: What to Ask Your Doctor or Nurse

  • Could I see a respiratory physiotherapist to help with mucus clearance?

  • What technique is best for my condition (e.g., ABPA vs. CPA)?

  • Can I be shown how to use a flutter device or Acapella safely?

  • What should I do if I feel worse after using a technique?

🗣️ “The physio made all the difference – she explained what my lungs were doing and helped me pick something that actually worked.”

💬 Final Word

🗣️ “It’s not just about technique – it’s about what fits your life. Small steps like staying hydrated, using huffing, and getting guidance made a big difference for me.”

There’s no one-size-fits-all approach – but with the right support, airway clearance can help you take control of your lungs, reduce flare-ups, and breathe easier.

by GAtherton

Biologics and Long Term Side Effects

✅ What Are Biologics?

Biologics are targeted treatments made from living cells. They work by blocking parts of the immune system that cause inflammation — for example:

  • IL-4, IL-5, IL-13: linked to eosinophilic inflammation

  • IgE: linked to allergies and ABPA

They are not immunosuppressants like steroids or chemotherapy, but rather immune modulators.

💊 Long-Term Side Effects – What Do We Know?

👨‍⚕️ What research and experience show:

Biologic Used for Long-term safety known? Side effects most reported
Omalizumab (Xolair) Allergic asthma, ABPA 20+ years of use Injection site reactions, headache, very rare anaphylaxis
Mepolizumab (Nucala) Eosinophilic asthma, CPA 10+ years Fatigue, headache, shingles (rare), mild infections
Benralizumab (Fasenra) Severe asthma, CPA ~6–7 years Headache, pharyngitis, injection site issues
Dupilumab (Dupixent) Asthma, eczema, nasal polyps 6–8 years Eye dryness/redness, cold sores, joint pain (rare)
Tezepelumab (Tezspire) Severe asthma ~2 years Sore throat, joint pain, injection site reactions

⚠️ Possible Long-Term Concerns (but rare)

  • Infections: Some concern about slightly increased risk of herpes zoster (shingles) or respiratory viruses, but overall risk is very low compared to steroids.

  • Immunogenicity: Your body might develop antibodies to the drug over time, reducing its effect — this is more a loss of benefit, not a dangerous side effect.

  • Cancer risk: No consistent evidence linking asthma/ABPA biologics to cancer.

  • Unknowns: Because some biologics are new (e.g. tezepelumab), we don't yet have 20-year data — but so far the safety profile is reassuring.

🩺 Compared to Oral Steroids

Treatment Side Effects Over Time
Steroids (e.g. prednisolone) Weight gain, diabetes, infections, bone thinning, cataracts, adrenal suppression
Biologics Mostly minor – injection site pain, headache, mild infection risk, rare allergic reaction

So in most cases, biologics reduce the need for steroids and therefore reduce long-term harm.

💬 Patient Experience

Most patients report:

  • Improved quality of life

  • Reduced asthma/ABPA attacks

  • Fewer hospital visits

  • Very few stop due to side effects

✅ Summary

Question Answer
Do biologics have long-term side effects? Usually mild and rare; mostly injection reactions or mild infections
Are they safer than long-term steroids? Yes, especially over years
Should I be worried? Not usually — but always monitor with your team
How long have they been used? 6–20+ years, depending on the biologic, with very good safety data

by GAtherton

🛡️ How Your Care is Changing: Understanding Antimicrobial Stewardship

A guide for patients with aspergillosis and chronic lung conditions

If you're being treated for chronic pulmonary aspergillosis (CPA), ABPA, or any long-term lung condition, you might notice changes in the way doctors use antifungal and antibiotic medicines. These changes are part of a worldwide effort to tackle antimicrobial resistance (AMR) — and to make sure the right treatment is used, in the right place, for the right reason.

💬 What is Antimicrobial Stewardship?

Antimicrobial stewardship (AMS) means using antifungal and antibiotic medications responsibly, so they work better now and stay effective for the future.

It’s about:

  • Using the right medication

  • In the right place

  • For the right reason

  • At the right dose and duration

This helps ensure patients get better faster, and we all stay protected from drug-resistant infections.

🔬 What Is Antimicrobial Resistance?

Antimicrobial resistance (AMR) happens when bacteria or fungi evolve and stop responding to medicines that used to work. This makes infections:

  • Harder to treat

  • More likely to come back

  • More dangerous for people with lung or immune conditions

There are two major types:

  • Antibiotic resistance (bacteria)

  • Antifungal resistance (fungi, including Aspergillus fumigatus)

💊 Antibiotics: Broad vs Narrow Spectrum

Doctors aim to use targeted antibiotics wherever possible. Here’s how they differ:

Type Description Examples Used For
Broad-spectrum Kills a wide range of bacteria Co-amoxiclav, meropenem, ceftriaxone Sepsis, serious infections
Narrow-spectrum Targets specific bacteria Penicillin, nitrofurantoin, flucloxacillin Simple infections

🧪 Doctors may start with broad-spectrum drugs in emergencies but switch to narrow-spectrum when test results are available — this is called de-escalation.

🦠 Antifungal Resistance and Aspergillosis

People with CPA or ABPA are often treated with antifungals like:

  • Itraconazole

  • Voriconazole

  • Posaconazole

  • Isavuconazole

But fungi can develop resistance, especially when:

  • Medications are used long-term

  • Fungi are exposed to azole sprays on crops and flowers

You may inhale resistant spores from:

  • Compost, potting soil, or garden centres

  • Fresh flowers (especially imported ones)

🏥 What Might You Notice in Hospital?

✅ Shorter or targeted treatment

  • You may be on 5–7 days of antibiotics/antifungals

  • Switch from IV to tablets happens earlier once you're stable

✅ Treatment reviews

  • Your medication will be reviewed within 48–72 hours

  • Changes may be made based on lab results

✅ More testing

  • Blood, sputum, or biopsy samples help identify infections and resistance

  • Ensures you get the right treatment

✅ Specialist involvement

  • An infection or respiratory consultant may review your case if resistant infection is suspected

✅ Infection control

  • You may notice:

    • No fresh flowers

    • HEPA filters in some wards

    • Staff using extra precautions to prevent airborne infections

🏡 What Might You Notice From Your GP?

✅ More specific prescribing

  • GPs are less likely to give antibiotics “just in case”

  • More narrow-spectrum choices based on the suspected infection

✅ Diagnostic support

  • GPs may send sputum or urine samples before prescribing

  • May test your blood for antifungal levels (TDM)

✅ Home safety advice

You may be advised to:

  • Avoid indoor compost or plant pots

  • Wear FFP2/FFP3 masks when gardening

  • Keep indoor air well ventilated

🧬 New Antifungals Being Protected for Patient Use

Several antifungals are in development and being reserved just for medical use (not agriculture), including:

Drug What it is Why it matters
Rezafungin Weekly IV echinocandin Long-lasting for serious infections
Ibrexafungerp First oral alternative to azoles Trials for aspergillosis
Olorofim New class (DHODH inhibitor) Active against resistant Aspergillus
Opelconazole Inhaled antifungal Direct treatment to the lungs
Fosmanogepix Novel target Works against drug-resistant fungi

🧠 What This All Means for You

These changes are about:

  • Better outcomes — faster recovery with fewer side effects

  • Preventing resistance — protecting future treatments

  • More personalised care — based on test results and your condition

✅ What You Can Do

Action Why It Helps
Take medications exactly as prescribed Prevents underdosing and resistance
Don’t stop treatment early Even if you feel better
Ask if your treatment has been reviewed Encourages early switch or adjustment
Use a mask and gloves for gardening Reduces spore exposure
Avoid fresh flowers and compost indoors Especially in bedrooms or when unwell
Report any new or worsening symptoms Resistance may be developing
Ask about resistance testing if you’re not improving Labs can check fungal response
Stay informed and speak up You’re part of the stewardship solution

📌 In Summary: Stewardship in Action

Antimicrobial stewardship is not about doing less — it's about doing things more precisely.
It’s how your healthcare team makes sure you receive:

The right medication, in the right place, for the right reason.

🔗 Want to Learn More?

by GAtherton

💊 General Strategies to Reduce Antimicrobial Resistance in Clinical Practice

1. IV to Oral Switch (IVOS)

One of the most effective and safe interventions in antimicrobial stewardship.

🔁 Why switch from IV to oral early?

  • Reduces complications (e.g. line infections, thrombosis)

  • Lowers costs and bed-days

  • Improves patient comfort and mobility

  • Oral options (e.g. ciprofloxacin, fluconazole, linezolid) are highly bioavailable, often matching IV efficacy

✅ When is IVOS appropriate?

  • Clinical improvement seen

  • Source controlled

  • Oral route available and tolerated

  • Suitable oral alternative exists

NHS guidance: "Start smart – then focus" encourages early IVOS reviews within 48–72 hours of antibiotic initiation.

2. "Start Smart – Then Focus" (UK NHS Framework)

This key NHS antimicrobial policy includes:

  • Start Smart: Prescribe antibiotics appropriately from the beginning

  • Then Focus:

    • Review at 48–72 hours

    • Consider stop, switch, change, or continue

    • Document clearly in records

Supported by NICE guidelines and UKHSA audits

3. Shorter Duration of Therapy

For many infections, shorter courses (e.g. 5–7 days instead of 10–14) are now preferred.

Examples:

  • Community-acquired pneumonia: 5 days

  • Pyelonephritis: 7 days

  • Cellulitis: 5–7 days

This reduces resistance pressure and side effects.

4. Diagnostics-Guided Prescribing

  • Procalcitonin and CRP tests can help distinguish bacterial from viral infections

  • Rapid PCR, MRSA, or blood culture diagnostics guide targeted therapy

The aim is avoid empirical broad-spectrum antibiotics where possible.

5. Restricted Prescribing Policies

  • Certain high-risk drugs (e.g. carbapenems, vancomycin, antifungals) are restricted to ID approval

  • Antimicrobials are tiered by risk (e.g. traffic light systems) to encourage narrow-spectrum use

6. Antimicrobial Stewardship Teams (ASTs)

Multidisciplinary teams:

  • Lead on stewardship strategy

  • Audit antimicrobial use

  • Provide decision support for complex cases

  • Educate staff and update local formularies

In the NHS, stewardship is a CQUIN target (incentivised performance indicator).

7. Education and Behaviour Change

  • Mandatory AMS training for junior doctors and prescribers

  • Behavioural nudges in electronic prescribing systems (e.g. default shorter durations, alert for IVOS)

8. Surveillance and Reporting

  • ePAMS+, ESPAUR, and PHE Fingertips dashboards track:

    • Prescribing by hospital/unit

    • Resistance trends

    • Audit compliance with IVOS, duration, and documentation

9. Patient-Facing Initiatives

  • "Antibiotic Guardian" and leaflets explaining viral vs bacterial infections

  • Empowering patients to ask:

    "Do I really need antibiotics? When can I switch to tablets?"

📦 Summary Table: Key Interventions

Strategy Purpose
IV to Oral Switch Reduce IV duration, speed discharge
Review at 48–72 hrs Reassess need, de-escalate if possible
Shorter therapy courses Lower resistance pressure
Targeted diagnostics Support narrow-spectrum prescribing
Prescribing restrictions Protect last-resort antimicrobials
Stewardship teams Oversee, audit, educate
Surveillance & feedback Monitor trends, guide policy

by GAtherton